Mueller Brian 4

What Happened
Brian Mueller, CFO of BioMarin Pharmaceutical (BMRN), disposed of 2,117 shares on 2026-03-17 at $56.05 per share for a total of approximately $118,658. The Form 4 lists the transaction code F, indicating the shares were surrendered or sold to satisfy tax withholding or to pay an exercise price related to an equity award or option.

Key Details

• Transaction date: 2026-03-17
• Price per share: $56.05
• Shares disposed: 2,117
• Proceeds (approx.): $118,658
• Transaction code: F (payment of exercise price or tax liability / tax withholding)
• Shares owned after transaction: not specified in the provided filing excerpt
• Filing date: 2026-03-19 (no indication in the provided data that the filing was late)

Context
This appears to be a routine tax-withholding or exercise-related disposition (often a cashless or share-surrender action) rather than an open-market sale expressing a view on the company. Such transactions are common around option exercises or vesting events and generally reflect tax obligations rather than a change in insider sentiment.